{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T03:57:18Z","timestamp":1754020638830,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00270-019-02294-7","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T17:02:31Z","timestamp":1564506151000},"page":"1494-1499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Short-Term Oral Sorafenib for Therapy of Intratumoral Shunts of Hepatocellular Carcinoma to Enable Intraarterial Treatment"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-5731","authenticated-orcid":false,"given":"J.","family":"Th\u00fcring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bruners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pedersoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schulze-Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Barzakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. K.","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Isfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"issue":"25","key":"2294_CR1","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3748\/wjg.v16.i25.3211","volume":"16","author":"H Ishii","year":"2010","unstructured":"Ishii H, Sonoyama T, Nakashima S, et al. Surgical treatment of hepatocellular carcinoma with severe intratumoral arterioportal shunt. WJG. 2010;16(25):3211.","journal-title":"WJG"},{"key":"2294_CR2","first-page":"3","volume-title":"Chemoembolization of hepatocellular carcinoma Seminars in interventional radiology","author":"R Lencioni","year":"2013","unstructured":"Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma Seminars in interventional radiology. Stuttgart: Thieme Medical Publishers; 2013. p. 3."},{"issue":"2","key":"2294_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00270-014-1012-0","volume":"38","author":"MB Pitton","year":"2015","unstructured":"Pitton MB, Kloeckner R, Ruckes C, et al. Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2015;38(2):352\u201360.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"2294_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0009-9260(97)80303-0","volume":"52","author":"H Ngan","year":"1997","unstructured":"Ngan H, Peh W. Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol. 1997;52(1):36\u201340.","journal-title":"Clin Radiol"},{"issue":"8","key":"2294_CR5","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s00330-009-1349-y","volume":"19","author":"S Murata","year":"2009","unstructured":"Murata S, Tajima H, Nakazawa K, Onozawa S, Kumita S, Nomura K. Initial experience of transcatheter arterial chemoembolization during portal vein occlusion for unresectable hepatocellular carcinoma with marked arterioportal shunts. Eur Radiol. 2009;19(8):2016\u201323.","journal-title":"Eur Radiol"},{"issue":"6","key":"2294_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF02603142","volume":"16","author":"PG Tarazov","year":"1993","unstructured":"Tarazov PG. Intrahepatic arterioportal fistulae: role of transcatheter embolization. Cardiovasc Intervent Radiol. 1993;16(6):368\u201373.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"2294_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1148\/radiology.204.3.9280260","volume":"204","author":"J Furuse","year":"1997","unstructured":"Furuse J, Iwasaki M, Yoshino M, et al. Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology. 1997;204(3):787\u201390.","journal-title":"Radiology"},{"issue":"1","key":"2294_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1634\/theoncologist.2008-0185","volume":"14","author":"RC Kane","year":"2009","unstructured":"Kane RC, Farrell AT, Madabushi R, et al. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Oncologist. 2009;14(1):95\u2013100.","journal-title":"Oncologist"},{"issue":"1","key":"2294_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/RLU.0000000000002369","volume":"44","author":"P d'Abadie","year":"2019","unstructured":"d'Abadie P, Borbath I, Goffette P, Amini N, Lhommel R. Sorafenib reduced significantly heptopulmonary shunt in a large hepatocelullar carcinoma. Clin Nucl Med. 2019;44(1):70\u20131.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2294_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4046\/trd.2016.79.3.179","volume":"79","author":"J Lee","year":"2016","unstructured":"Lee J, Kim YJ, Kim HJ, Kim JM, Kim YC, Choi SM. Acute respiratory failure caused by hepatopulmonary fistula in a patient with hepatocellular carcinoma. Tuberc Respir Dis. 2016;79(3):179\u201383.","journal-title":"Tuberc Respir Dis"},{"issue":"1","key":"2294_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","volume":"68","author":"A Kennedy","year":"2007","unstructured":"Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol* Biol* Phys 68(1):13\u201323","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"issue":"7","key":"2294_CR12","first-page":"949","volume":"23","author":"JM Theysohn","year":"2012","unstructured":"Theysohn JM, Schlaak JF, Muller S et al (2012) Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration. JVIR 23(7):949\u2013952","journal-title":"JVR"},{"issue":"8","key":"2294_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/0284185115605680","volume":"57","author":"C Erxleben","year":"2016","unstructured":"Erxleben C, Scheurig-Munkler C, Geisel D, Hamm B, Gebauer B, Powerski MJ (2016) Hepatopulmonary shunting after surgical, interventional and systemic therapy in patients with liver malignancies scheduled for radioembolization. Acta Radiol (Stockholm, Sweden 1987) 57(8):908\u2013913","journal-title":"Acta Radiol (Stockholm, Sweden 1987)"},{"issue":"6","key":"2294_CR14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s00330-011-2368-z","volume":"22","author":"W Sieghart","year":"2012","unstructured":"Sieghart W, Pinter M, Reisegger M, et al. Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study. Eur Radiol. 2012;22(6):1214\u201323.","journal-title":"Eur Radiol"},{"issue":"12","key":"2294_CR15","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10620-013-2872-x","volume":"58","author":"O Abdel-Rahman","year":"2013","unstructured":"Abdel-Rahman O, Elsayed Z. Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature. Dig Dis Sci. 2013;58(12):3389\u201396.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2294_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.critrevonc.2010.03.006","volume":"78","author":"J Bellmunt","year":"2011","unstructured":"Bellmunt J, Eisen T, Fishman M, Quinn D. Experience with sorafenib and adverse event management. Crit Rev Oncol Hematol. 2011;78(1):24\u2013322.","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-019-02294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-019-02294-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-019-02294-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:15:09Z","timestamp":1595978109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-019-02294-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1007\/s00270-019-02294-7","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"type":"print","value":"0174-1551"},{"type":"electronic","value":"1432-086X"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"22 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}